Correlation Between Bio Gene and Epsilon Healthcare

Can any of the company-specific risk be diversified away by investing in both Bio Gene and Epsilon Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Epsilon Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Gene Technology and Epsilon Healthcare, you can compare the effects of market volatilities on Bio Gene and Epsilon Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Epsilon Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Epsilon Healthcare.

Diversification Opportunities for Bio Gene and Epsilon Healthcare

0.0

Correlation Coefficient

Bio Gene  Epsilon Healthcare

Pay attention - limited upside

The 3 months correlation between Bio and Epsilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Epsilon Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Epsilon Healthcare and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Epsilon Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Epsilon Healthcare has no effect on the direction of Bio Gene i.e., Bio Gene and Epsilon Healthcare go up and down completely randomly.

Pair Corralation between Bio Gene and Epsilon Healthcare

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Epsilon Healthcare. In addition to that, Bio Gene is 1.2 times more volatile than Epsilon Healthcare. It trades about -0.01 of its total potential returns per unit of risk. Epsilon Healthcare is currently generating about 0.02 per unit of volatility. If you would invest  2.60  in Epsilon Healthcare on October 11, 2024 and sell it today you would lose (0.20) from holding Epsilon Healthcare or give up 7.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bio Gene Technology  vs.  Epsilon Healthcare

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Epsilon Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Epsilon Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Epsilon Healthcare is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Bio Gene and Epsilon Healthcare

The main advantage of trading using opposite Bio Gene and Epsilon Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Epsilon Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epsilon Healthcare will offset losses from the drop in Epsilon Healthcare's long position.

The idea behind Bio Gene Technology and Epsilon Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.